Document is current

Documents that mention this clinical trial

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
https://doi.org/10.1136/openhrt-2019-001153

Documents that mention this clinical trial

New drugs in preclinical and early stage clinical development in the treatment of heart failure
https://doi.org/10.1080/13543784.2019.1551357

Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
https://doi.org/10.1161/circulationaha.122.060757

Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
https://doi.org/10.1186/s12933-023-01943-z

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
https://doi.org/10.1136/openhrt-2019-001153

Documents that mention this clinical trial

New drugs in preclinical and early stage clinical development in the treatment of heart failure
https://doi.org/10.1080/13543784.2019.1551357

Rationale and design of a randomised trial of intravenous iron in patients with heart failure
https://doi.org/10.1136/heartjnl-2022-321304

Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
https://doi.org/10.1136/heartjnl-2024-324908

Iron deficiency in 78 805 people admitted with heart failure across England: a retrospective cohort study
https://doi.org/10.1136/openhrt-2019-001153

137 Efficacy of intravenous ferric derisomaltose in hospitalised and outpatient settings: insights from ironman trial
https://doi.org/10.1136/heartjnl-2024-bcs.135